LD 538

Maine House of Representatives bill in Session 132.

Status: enacted. Latest action: May 27, 2025.

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives.

Bill ID ME-132-LD-538

Session 132

Status enacted

Committee Health Coverage, Insurance and Financial Services

House of Representatives enacted 2025-05-27

Summary

AMEND MAINE'S PRESCRIPTION DRUG LABELING LAW BY ALLOWING

Sponsor

Sally Jeane Cluchey

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2025-02-11	Introduced	Bill introduced
2025-05-27	Status	enacted
2025-05-27	Latest Action	PASSED TO BE ENACTED, in concurrence.

More Bills From This Sponsor

LD 2123

Resolve, to Improve Dental Care Access by Modifying the MaineCare Reimbursement Methodology for the Provision of Certain Dental Services

enacted • House of Representatives

LD 338

An Act to Increase the Size and Balance of Jury Pools

enacted • House of Representatives

LD 2208

An Act to Offset Federal Cuts to Health Insurance for Certain Maine Families and Seniors

enrolled • House of Representatives

LD 2071

An Act to Expand Access to Vaccines Approved by the United States Food and Drug Administration by Allowing Pharmacists to Prescribe, Dispense and Administer Vaccines and Require Insurance Coverage

enacted • House of Representatives

LD 2078

An Act to Exempt from Sales Tax the Sale and Delivery of All Residential Electricity

enrolled • House of Representatives

LD 874

An Act to Provide Relief to Federal or State Employees Affected by a Federal Government or State Government Shutdown

enacted • House of Representatives